Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1950 1
1952 1
1955 2
1956 1
1957 2
1959 1
1961 1
1962 1
1963 3
1965 3
1966 2
1968 2
1969 1
1972 1
1973 1
1974 1
1979 1
1980 1
1981 2
1982 1
1984 1
1985 7
1986 6
1987 4
1988 4
1989 9
1990 4
1991 8
1992 9
1993 5
1994 7
1996 6
1997 2
1998 4
1999 3
2000 5
2001 9
2002 5
2003 4
2004 5
2005 4
2006 4
2007 2
2008 4
2009 1
2010 3
2011 1
2012 2
2013 3
2014 1
2015 4
2016 5
2017 7
2018 7
2019 3
2020 4
2021 13
2022 6
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

211 results

Results by year

Filters applied: . Clear all
Page 1
Sirt2 Inhibition Enhances Metabolic Fitness and Effector Functions of Tumor-Reactive T Cells.
Hamaidi I, Zhang L, Kim N, Wang MH, Iclozan C, Fang B, Liu M, Koomen JM, Berglund AE, Yoder SJ, Yao J, Engelman RW, Creelan BC, Conejo-Garcia JR, Antonia SJ, Mulé JJ, Kim S. Hamaidi I, et al. Among authors: mule jj. Cell Metab. 2020 Sep 1;32(3):420-436.e12. doi: 10.1016/j.cmet.2020.07.008. Epub 2020 Aug 7. Cell Metab. 2020. PMID: 32768387 Free PMC article.
Genomic and Single-Cell Landscape Reveals Novel Drivers and Therapeutic Vulnerabilities of Transformed Cutaneous T-cell Lymphoma.
Song X, Chang S, Seminario-Vidal L, de Mingo Pulido A, Tordesillas L, Song X, Reed RA, Harkins A, Whiddon S, Nguyen JV, Segura CM, Zhang C, Yoder S, Sayegh Z, Zhao Y, Messina JL, Harro CM, Zhang X, Conejo-Garcia JR, Berglund A, Sokol L, Zhang J, Rodriguez PC, Mulé JJ, Futreal AP, Tsai KY, Chen PL. Song X, et al. Among authors: mule jj. Cancer Discov. 2022 May 2;12(5):1294-1313. doi: 10.1158/2159-8290.CD-21-1207. Cancer Discov. 2022. PMID: 35247891 Free PMC article.
Epigenetic state determines the in vivo efficacy of STING agonist therapy.
Falahat R, Berglund A, Perez-Villarroel P, Putney RM, Hamaidi I, Kim S, Pilon-Thomas S, Barber GN, Mulé JJ. Falahat R, et al. Among authors: mule jj. Nat Commun. 2023 Mar 22;14(1):1573. doi: 10.1038/s41467-023-37217-1. Nat Commun. 2023. PMID: 36949064 Free PMC article.
The 12-CK Score: Global Measurement of Tertiary Lymphoid Structures.
Li R, Berglund A, Zemp L, Dhillon J, Putney R, Kim Y, Jain RK, Grass GD, Conejo-Garcia J, Mulé JJ. Li R, et al. Among authors: mule jj. Front Immunol. 2021 Jun 29;12:694079. doi: 10.3389/fimmu.2021.694079. eCollection 2021. Front Immunol. 2021. PMID: 34267760 Free PMC article. Review.
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma.
Hall MS, Mullinax JE, Cox CA, Hall AM, Beatty MS, Blauvelt J, Innamarato P, Nagle L, Branthoover H, Wiener D, Schachner B, Martinez AJ, Richards AD, Rich CJ, Colón Colón M, Schell MJ, Teer JK, Khushalani NI, Weber JS, Mulé JJ, Sondak VK, Pilon-Thomas S, Sarnaik AA. Hall MS, et al. Among authors: mule jj. Clin Cancer Res. 2022 Dec 15;28(24):5317-5329. doi: 10.1158/1078-0432.CCR-22-2103. Clin Cancer Res. 2022. PMID: 36215121 Free PMC article. Clinical Trial.
Ectopic lymph nodes within human solid tumors.
Coppola D, Mulé JJ. Coppola D, et al. Among authors: mule jj. J Clin Oncol. 2008 Sep 20;26(27):4369-70. doi: 10.1200/JCO.2008.17.6149. J Clin Oncol. 2008. PMID: 18802146 No abstract available.
Making room for T cells.
Maine GN, Mulé JJ. Maine GN, et al. Among authors: mule jj. J Clin Invest. 2002 Jul;110(2):157-9. doi: 10.1172/JCI16166. J Clin Invest. 2002. PMID: 12122106 Free PMC article. Review. No abstract available.
Dendritic cell-based therapeutics for breast cancer.
Pilon-Thomas SA, Verhaegen ME, Mulé JJ. Pilon-Thomas SA, et al. Among authors: mule jj. Breast Dis. 2004;20:65-71. doi: 10.3233/bd-2004-20108. Breast Dis. 2004. PMID: 15687708 Review.
Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinoma.
Chakiryan NH, Kim Y, Berglund A, Chang A, Kimmel GJ, Hajiran A, Nguyen J, Moran-Segura C, Saeed-Vafa D, Katende EN, Lopez-Blanco N, Chahoud J, Rappold P, Spiess PE, Fournier M, Jeong D, Wang L, Teer JK, Dhillon J, Kuo F, Hakimi AA, Altrock PM, Mulé JJ, Manley BJ. Chakiryan NH, et al. Among authors: mule jj. J Immunother Cancer. 2023 Apr;11(4):e006195. doi: 10.1136/jitc-2022-006195. J Immunother Cancer. 2023. PMID: 37185232 Free PMC article.
Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients.
Hall MS, Teer JK, Yu X, Branthoover H, Snedal S, Rodriguez-Valentin M, Nagle L, Scott E, Schachner B, Innamarato P, Hall AM, Blauvelt J, Rich CJ, Richards AD, Ceccarelli J, Langer TJ, Yoder SJ, Beatty MS, Cox CA, Messina JL, Abate-Daga D, Mule JJ, Mullinax JE, Sarnaik AA, Pilon-Thomas S. Hall MS, et al. Among authors: mule jj. J Immunother Cancer. 2023 Oct;11(10):e007288. doi: 10.1136/jitc-2023-007288. J Immunother Cancer. 2023. PMID: 37802604 Free PMC article.
211 results